N6-methyladenine RNA modification and cancers.

Area of Science:

• Epigenetics and Molecular Biology
• Cancer Research
• RNA Biology

Background:

• N6-methyladenine (m⁶A) is a dynamic and reversible RNA modification, analogous to DNA methylation.
• m⁶A modifications are regulated by specific enzymes (methyltransferases and demethylases) and influence gene expression.
• m⁶A-binding proteins mediate the biological functions of m⁶A-modified RNA.

Purpose of the Study:

• To comprehensively review the roles of mRNA m⁶A modifications in human cancer development.
• To explore the dualistic function of m⁶A modifications as either oncogenic or tumor-suppressive in different cancer types.
• To emphasize the significance of studying m⁶A-regulated genes for understanding cancer pathogenesis.

Main Methods:

• Literature review of existing studies on m⁶A modifications in cancer.
• Analysis of the reported functions of m⁶A methyltransferases, demethylases, and binding proteins in oncogenesis.
• Synthesis of information regarding the impact of m⁶A on gene expression in various human cancers.

Main Results:

• m⁶A modifications play critical roles in diverse human cancers, including lung cancer, brain tumors, and leukemia.
• The role of m⁶A modifications in cancer is context-dependent, exhibiting both oncogenic and tumor-suppressive activities.
• Specific m⁶A-modified genes and their regulatory pathways are implicated in cancer progression.

Conclusions:

• mRNA m⁶A modifications are integral to cancer biology, influencing multiple aspects of tumor development.
• Understanding the specific functions of m⁶A-regulated genes is essential for deciphering cancer mechanisms.
• Targeting key m⁶A-related genes holds potential for future cancer diagnostics and therapeutics.